Trial
NCT01593241
Therapy De-escalation in Seminoma Stage IIA/B
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Swiss Cancer Institute
Collaborators
—
Condition
Seminoma
Intervention
Carboplatin
Why stopped
Board decided to prematurely terminate the follow-up phase of the trial due to funding reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-13